Posted on behalf of Phillips Law Group on Oct 25, 2021 in Defective Drug
Last week, Lupin Pharmaceuticals voluntarily recalled two types of blood pressure medication because they may have high levels of an impurity that may cause cancer.
The recall includes all irbesartan tablets, including 75 milligram (mg), 150 mg and 300 mg tablets. The recall also includes all batches of irbesartan plus hydrochlorothiazide tablets (150 mg/12.5 mg and 300 mg/12.5 mg).
These drugs are used to treat high blood pressure and were being distributed in 30 and 90-count bottles across the nation. Irbesartan was also prescribed to treat diabetic nephropathy in patients with type 2 diabetes who also have high blood pressure and elevated proteinuria and serum creatinine.
Lupin chose to do the recall out of an abundance of caution. The company said it has not received any reports of illness related to the impurity (N-nitrosoirbesartan). Although the pills were still on the market before the recall, Lupin had stopped marketing the drugs in January. This came after the company received four reports of illness among those taking irbesartan between October 2018 and September 2021.
If you are currently taking one of these medications, the U.S. Food and Drug Administration (FDA) says you should keep taking it and talk to your doctor or pharmacist for advice on an alternative medication to treat high blood pressure. Adverse reactions should be reported to the FDA’s MedWatch Adverse Event Reporting Program. This can be done via the website or fax or regular mail.
Lupin is in contact with wholesalers, distributors, drug chains, mail order pharmacies and supermarkets to arrange for the remaining pills to be returned to the manufacturer.
Those injured by defective drugs should strongly consider seeking legal help. The experienced defective drug lawyers at Phillips Law Group are here to answer your questions and discuss potential legal options at no upfront cost and with no obligation.
Give us a call today to learn more. Call 1-800-706-3000.
The Phillips Law Group. All rights reserved. All materials contained on the Phillips Law Group website are copyrighted including trademarks, and other proprietary information including the content on its blogs, the home page, and all website pages. The material contained on this website may not be copied, reproduced, modified, transmitted, displayed, or distributed without written permission of the Phillips Law Group. Any reposting, distribution, or displaying of website content on any other business website without prior written consent is a violation of copyright laws. The Phillips Law Group disclaims all liability for content maintained on other websites that are linked to this firm's website.
PMP Marketing Group